Ciprofloxacin (BAYO9867)

DRUG2 trials

Sponsors

Bayer, Al-Mustafa University College

Conditions

Bacterial InfectionsBurnsCutaneous Leishmaniasis

Phase 2

Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

RecruitingNCT06798402

Al-Mustafa University CollegeCutaneous Leishmaniasis

Start: 2025-02-07End: 2025-11-01Target: 80Updated: 2025-09-30

Phase 3

Ciprofloxacin on Burned Patients

CompletedNCT00668044

BayerBacterial Infections, Burns

Start: 2002-11-30End: 2003-11-30Updated: 2009-10-27